J&J Pulls Infant Tylenol From Shelves in Consumer Unit’s Latest Recall

Johnson & Johnson, the world’s second biggest health-care company, voluntarily pulled more than a half-million bottles of infants’ Tylenol from shelves in the latest in a string of recalls.

The oral grape Tylenol, distributed nationwide, was recalled after a “small number of complaints” with the bottle’s SimpleMeasure dosing system, the New Brunswick, New Jersey-based drugmaker said in a statement. The bottle comes with a syringe and a barrier that limits the flow to the correct dose, which some customers said was pushed into the bottle during use.

“No adverse events associated with this action have been reported to date and the risk of a serious adverse medical event is remote,” J&J said in the statement.

The company shifted management of its over-the-counter products business last month. J&J has recalled hundreds of millions of packets of Tylenol, Motrin, Benadryl and other products due to foul odors, adulterated ingredients and bad labeling in the last two years.

Customers can continue using Infants’ Tylenol as long as the flow restrictor remains at the top of the bottle, the company said. Children’s Tylenol, for kids more than two years old, is still available.

To contact the reporter on this story: Sarah Frier in New York at sfrier1@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.